Interacciones de Dinoprostona

Dinoprostona (Cervidil, Prepidil, Prostin E2), análogo de prostaglandina, tiene 36 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 3; moderadas: 28; leves: 5; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (3)

  • …fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.8 , 5.9) ] • Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac sodium and misoprostol, other prostaglandins, or any components of the drug product [see Warnings and Precautions (5.8 , 5.10) ] • Pregnancy ( 4 ) (etiqueta de Diclofenaco y misoprostol, Contraindicaciones)

  • KetorolacoAINEGrave

    Ketorolac tromethamine is contraindicated in labor and delivery because, through its prostaglandin synthesis inhibitory effect, it may adversely affect fetal circulation and inhibit uterine contractions, thus increasing the risk of uterine hemorrhage. (etiqueta de Ketorolaco, Contraindicaciones)

  • Latanoprostanálogo de prostaglandinaGrave

    The combined use of two or more prostaglandins, or prostaglandin analogs including XELPROS is not recommended. (etiqueta de Latanoprost, Interacciones medicamentosas)

Interacciones moderadas (28)

  • Ácido mefenámicoAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Ácido mefenámico, Advertencias y precauciones)

  • AtenololbetabloqueanteModerada

    Concomitant use of prostaglandin synthase inhibiting drugs, e.g., indomethacin, may decrease the hypotensive effects of beta-blockers. (etiqueta de Atenolol, Interacciones medicamentosas)

  • Atenolol y clortalidonabetabloqueanteModerada

    Concomitant use of prostaglandin synthase inhibiting drugs, e.g., indomethacin, may decrease the hypotensive effects of beta-blockers. (etiqueta de Atenolol y clortalidona, Interacciones medicamentosas)

  • CelecoxibAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Celecoxib, Advertencias y precauciones)

  • DiclofenacoAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Diclofenaco, Advertencias y precauciones)

  • DiflunisalAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Diflunisal, Advertencias)

  • EtodolacoAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Etodolaco, Advertencias)

  • FenoprofenoAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Fenoprofeno, Advertencias y precauciones)

  • FlurbiprofenoAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Flurbiprofeno, Advertencias y precauciones)

  • Furosemidadiurético de asaModerada

    Indomethacin Coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of furosemide in some patients by inhibiting prostaglandin synthesis. (etiqueta de Furosemida, Interacciones medicamentosas)

  • Renal Toxicity and Hyperkalemia Renal Toxicity Long-term administration of NSAIDs has resulted in renal papillary necrosis and other renal injury.Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Hidrocodona e ibuprofeno, Advertencias)

  • IbuprofenoAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Ibuprofeno, Advertencias y precauciones)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Ibuprofeno y famotidina, Advertencias y precauciones)

  • IndometacinaAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Indometacina, Advertencias y precauciones)

  • KetoprofenoAINEModerada

    A second form of renal toxicity has been seen in patients with conditions leading to a reduction in renal blood flow or blood volume, where renal prostaglandins have a supportive role in the maintenance of renal blood flow. (etiqueta de Ketoprofeno, Advertencias y precauciones)

  • MeloxicamAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Meloxicam, Advertencias y precauciones)

  • Metilergometrinaalcaloide ergóticoModerada

    Caution should be exercised when methylergonovine maleate is used concurrently with other vasoconstrictors, ergot alkaloids, or prostaglandins. (etiqueta de Metilergometrina, Interacciones medicamentosas)

  • NabumetonaAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Nabumetona, Advertencias)

  • NaproxenoAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Naproxeno, Advertencias y precauciones)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Naproxeno y esomeprazol, Advertencias y precauciones)

  • OxaprozinaAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Oxaprozina, Advertencias y precauciones)

  • OxitocinaModerada

    Prostaglandins, including CERVIDIL, may potentiate the effect of oxytocin [see Drug Interactions (7) ] . (etiqueta de Dinoprostona, Advertencias y precauciones)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Paracetamol e ibuprofeno, Advertencias y precauciones)

  • PiroxicamAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Piroxicam, Advertencias y precauciones)

  • SalsalatoAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Salsalato, Advertencias)

  • SulindacoAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion.In these patients, administration of a non-steroidal anti-inflammatory drug may cause a dose-dependent reduction in prostaglandin formation and, secondarily, in renal blood flow, which may precipitate overt renal decompensation. (etiqueta de Sulindaco, Advertencias)

  • Sumatriptán y naproxenotriptánModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Sumatriptán y naproxeno, Advertencias y precauciones)

  • TolmetinaAINEModerada

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (etiqueta de Tolmetina, Advertencias)

Menciones leves (5)

  • Carboprostanálogo de prostaglandinaLeve

    Evidence from animal studies has suggested that certain other prostaglandins have some teratogenic potential. (etiqueta de Carboprost, Advertencias)

  • Cloruro de potasiosuplemento de potasioLeve

    Nonsteroidal Anti-inflammatory Drugs (NSAIDs) NSAIDs may produce potassium retention by reducing renal synthesis of prostaglandin E and impairing the renin-angiotensin system. (etiqueta de Cloruro de potasio, Interacciones medicamentosas)

  • EnoxaparinaanticoagulanteLeve

    Therapy consisting of prompt removal of the source of procoagulant material, replacement of depleted clotting factors and, in some cases, anti-coagulation with heparin should be instituted promptly. (etiqueta de Dinoprostona, Advertencias y precauciones)

  • HeparinaanticoagulanteLeve

    Therapy consisting of prompt removal of the source of procoagulant material, replacement of depleted clotting factors and, in some cases, anti-coagulation with heparin should be instituted promptly. (etiqueta de Dinoprostona, Advertencias y precauciones)

  • Treprostiniloanálogo de prostaglandinaLeve

    Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (etiqueta de Treprostinilo, Advertencias y precauciones)

Compruebe Dinoprostona frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.